Ginsenosides regulation of lysophosphatidylcholine profiles underlies the mechanism of Shengmai Yin in attenuating atherosclerosis

The traditional Chinese medicine (TCM) preparation, Shengmai Yin (SMY), is widely applied in cardiovascular disease treatments. However, the pharmacological mechanism of its therapeutic effects has not been fully clarified. This study aimed to clearly define the efficacy and underlying mechanism of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of ethnopharmacology 2021-09, Vol.277, p.114223, Article 114223
Hauptverfasser:	Wang, Yun, Wu, Jiawei, Zhu, Jiaying, Ding, Chujie, Xu, Wanfeng, Hao, Haiping, Zhang, Jun, Wang, Guangji, Cao, Lijuan
Format:	Artikel
Sprache:	eng
Schlagworte:	Atherosclerosis blood serum cholesterol cytokines Ginsenosides high fat diet histology homeostasis hypercholesterolemia Lipidomics Lysophosphatidylcholine Metabolomics mice Oriental traditional medicine Panax phospholipases risk factors Shengmai Yin therapeutics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!